Document is current
Any future updates will be listed below
-
Authors
Albers, Antonia
Kuniß, Nadine
Kloos, Christof
Wolf, Gunter
Schmidt, Sebastian
Müller, Nicolle https://orcid.org/0000-0002-0303-7322
-
Funding
Funding for this research was provided by:
Universitätsklinikum Jena
- License Information
-
More Information
Article History
Received: 16 June 2025
Accepted: 23 December 2025
First Online: 9 January 2026
Declarations
:
: As this study involved retrospective analysis of data routinely collected during standard clinical care, and no additional procedures or interventions were conducted, formal ethics approval was not required in accordance with local regulations. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000.
: Antonia Albers reports conflicts reimbursement for attending symposiums from Biomarin GmbH, metaX Institut, Dr. Schär AG, Nutricia metabolics and Vitaflo Deutschland GmbH. Nicolle Müller conflict for an honorarium for the advisory board from Biomarin GmbH and reimbursement for attending symposiums from Biomarin GmbH, Dr. Schär AG, metaX Institut for Ditäteik GmbH, Nutricia metabolics GmbH and speaker fees from metaX Institut and Biomarin GmbH. Sebastian Schmidt reports conflict for consulting or speaker fees from BioMarin GmbH, Immedica Pharma Germany GmbH, Novartis Deutschland GmbH and reimbursement for attending symposiums from metaX Institut für Diätetik GmbH (metaX), Sanofi-Aventis Deutschland GmbH, BioMarin GmbH Deutschland, Novartis Pharma GmbH, Recordati Rare Diseases Germany GmbH, Ascendis Pharma Endocrinology GmbH, Vitaflo Deutschland GmbH and honorarium for the advisory board from Biomarin GmbH and Immedica Pharma Germany GmbH. Nadine Kuniß, Christof Kloos and Gunter Wolf have no conflicts of interest to disclose.
